Typhoid fever and childhood vaccine strategies

Lancet

Volumn 354, Issue 9180, 1999, Pages 698-699

  Griffin, George E ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORAMPHENICOL; CIPROFLOXACIN; TYPHOID VACCINE;

ADOLESCENT; ADULT; ANTIBIOTIC RESISTANCE; BACTEREMIA; BLOOD CULTURE; CHILD; DEVELOPING COUNTRY; HUMAN; MAJOR CLINICAL STUDY; NOTE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SALMONELLA TYPHI; TYPHOID FEVER;

EID: 0033612949     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(99)90117-4     Document Type: Note

References (5)

1. Berkley J., Mwarumba S., Bramham K.et al. Bacteraemia complicating severe malaria in children. Trans R Soc Trop Med Hyg. 93:1999;283-286.
2. Levine M.M., Tacket C.O., Galen J.E.et al. Progress in development of new attenuated strains of Salmonella typhi as live oral vaccines against typhoid fever. Levine M.M., Woodrow G.C., Kaper J.B., Colson G.S. New generation vaccines, 2nd edn. 1997;437-447 Pub Marcel Dekker, New York.
3. Koff R.S. The case for routine childhood vaccination against hepatitis A. N Engl J Med. 340:1999;644-645.
4. Levine O.S., Schwartz B. Economic analysis of vaccines and vaccination programmes: evaluating the economic rationale for immunization. Levine M.M., Woodrow G.C., Kaper J.B., Colson G.S. New generation vaccines 2nd ed. 1997;69-79 Marcel Dekker.
5. Meeting on vaccine development and delivery; partnership for the 21st century. Bellagio, Italy: Rockefeller Foundation, 1999.